Literature DB >> 28473621

Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways.

Jin Han1,2,3, Xu Zhang2, Jennifer Oderinde2, Santosh L Saraf2, Michel Gowhari2, Joharah Hassan2, Shivi Jain2, Victor R Gordeuk2, Robert E Molokie4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28473621      PMCID： PMC5541880          DOI： 10.3324/haematol.2017.169128

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Increased clearance of morphine in sickle cell disease: implications for pain management.

Authors:  Deepika S Darbari; Michael Neely; John van den Anker; Sohail Rana
Journal:  J Pain       Date:  2011-02-01       Impact factor: 5.820

2.  Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects.

Authors:  T A Golper; H M Noonan; L Elzinga; D Gilbert; R Brummett; J L Anderson; W M Bennett
Journal:  Clin Pharmacol Ther       Date:  1988-05       Impact factor: 6.875

Review 3.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael Rybak; Ben Lomaestro; John C Rotschafer; Robert Moellering; William Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Am J Health Syst Pharm       Date:  2009-01-01       Impact factor: 2.637

Review 4.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

Review 5.  The spleen and sickle cell disease: the sick(led) spleen.

Authors:  Valentine Brousse; Pierre Buffet; David Rees
Journal:  Br J Haematol       Date:  2014-05-26       Impact factor: 6.998

6.  Sub-optimal serum gentamicin concentrations in sickle cell disease patients utilizing the Hartford protocol.

Authors:  A A Abusham; A H Mohammed; S S Alkindi; M M Hassan; I S Al-Zakwani
Journal:  J Clin Pharm Ther       Date:  2011-04-19       Impact factor: 2.512

Review 7.  Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics.

Authors:  Athena L V Hobbs; Katherine M Shea; Kirsten M Roberts; Mitchell J Daley
Journal:  Pharmacotherapy       Date:  2015-11       Impact factor: 4.705

8.  Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease.

Authors:  Xu Zhang; Wei Zhang; Shwu-Fan Ma; Ankit A Desai; Santosh Saraf; Galina Miasniakova; Adelina Sergueeva; Tatiana Ammosova; Min Xu; Sergei Nekhai; Taimur Abbasi; Nancy G Casanova; Martin H Steinberg; Clinton T Baldwin; Paola Sebastiani; Josef T Prchal; Rick Kittles; Joe G N Garcia; Roberto F Machado; Victor R Gordeuk
Journal:  Circulation       Date:  2014-02-10       Impact factor: 29.690

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Determining glomerular filtration rate in homozygous sickle cell disease: utility of serum creatinine based estimating equations.

Authors:  Monika R Asnani; O'Neil Lynch; Marvin E Reid
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.